Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
84%
OVERLAP
BY WEIGHT
60
# OF OVERLAPPING
HOLDINGS
XLV
60
HOLDINGS
100%
ALSO IN VHT
VHT
420
HOLDINGS
16%
ALSO IN XLV
SECTOR DRIFT (XLV minus VHT)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XLV |
Weight in VHT |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 12.5% | 11.1% | 11.1% | |
UNITEDHEALTH GROUP INC | 5.8% | 5.0% | 5.0% | |
ABBVIE INC | 6.6% | 4.8% | 4.8% | |
JOHNSON & JOHNSON | 7.5% | 4.6% | 4.6% | |
ABBOTT LABORATORIES | 4.8% | 4.1% | 4.1% |
XLV Overweight Relative to VHT
JOHNSON & JOHNSON | 3.0% | |
ABBVIE INC | 1.8% | |
ELI LILLY & CO | 1.5% | |
UNITEDHEALTH GROUP INC | 0.8% | |
ABBOTT LABORATORIES | 0.7% | |
MERCK & CO. INC. | 0.6% | |
INTUITIVE SURGICAL INC | 0.5% | |
BOSTON SCIENTIFIC CORP | 0.5% | |
THERMO FISHER SCIENTIFIC INC | 0.4% | |
AMGEN INC | 0.4% |
XLV Underweight Relative to VHT
VEEVA SYSTEMS INC-CLASS A | -0.8% | |
ALNYLAM PHARMACEUTICALS INC | -0.7% | |
NATERA INC | -0.4% | |
INSMED INC | -0.3% | |
TENET HEALTHCARE CORP | -0.3% | |
ILLUMINA INC | -0.3% | |
ROYALTY PHARMA PLC CLASS A | -0.2% | |
NEUROCRINE BIOSCIENCES INC | -0.2% | |
ENCOMPASS HEALTH CORPORATION | -0.2% | |
UNITED THERAPEUTICS CORP | -0.2% |